Cash Flow Statement

Altimmune (ALT) EBITDA Margin Growth (5y) (2015 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Altimmune 379.61 Mn 379.61 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -10.44 Mn
Sep 30, 2025 -37.92 Mn
Jun 30, 2025 -44.33 Mn
Mar 31, 2025 -39.19 Mn
Dec 31, 2024 -46.54 Mn
Sep 30, 2024 -44.83 Mn
Jun 30, 2024 -49.32 Mn
Mar 31, 2024 -49.09 Mn
Dec 31, 2023 -8.42 Mn
Sep 30, 2023 -560,550.00
Jun 30, 2023 -26.86 Mn
Mar 31, 2023 -9.49 Mn
Dec 31, 2022 -8.28 Mn
Sep 30, 2022 -118.23 Mn
Jun 30, 2022 -25.28 Mn
Mar 31, 2022 -5.94 Mn
Dec 31, 2021 -30,498.00
Sep 30, 2021 10.26 Mn
Jun 30, 2021 -1.74 Mn
Mar 31, 2021 -165,217.00
Dec 31, 2020 -38,771.00
Sep 30, 2020 -46,473.00
Jun 30, 2020 -18,857.00
Mar 31, 2020 -19,402.00
Dec 31, 2019 -56,964.00
Sep 30, 2019 -128,443.00
Jun 30, 2019 -17,731.00
Mar 31, 2019 -785.00
Dec 31, 2018 -80,923.00
Sep 30, 2018 119.00
Jun 30, 2018 -38,919.00
Mar 31, 2018 -7,903.00
Dec 31, 2017 -14,557.00
Sep 30, 2017 -64,799.00
Jun 30, 2017 -3,792.00
Mar 31, 2017 -130,902.00
Dec 31, 2016 -40,666.00
Sep 30, 2016 -12.37 Mn
Jun 30, 2016 -67,229.00
Mar 31, 2016 -4,935.00
Dec 31, 2015 3,404.00
Sep 30, 2015 -8,657.00
Jun 30, 2015 -5,188.00